|
Austria-GR-GR Azienda Directories
|
Azienda News:
- Scientific Breakthrough Unveils Promising New Path for Rheumatoid . . .
"Rheumatoid arthritis is a common health condition which can interfere with many aspects of daily life and based on the limited efficacy of current treatments, novel approaches are needed," says Dr Abdul-Sater This targeted approach could offer new hope for individuals who haven't found adequate relief with existing therapies
- New Drugs Medications Developed to Treat Rheumatoid Arthritis - WebMD
Recent studies show that some of the first DMARDs -- hydroxychloroquine (Plaquenil), methotrexate (Otrexup, Rheumatrex, Trexall), and sulfasalazine (Azulfidine, Azulfidine EN-tabs) -- when
- Breakthrough Rheumatology Trends and Innovations for 2025
Here’s a closer look at the most promising therapies from 2024 and key trends to watch in the 2025 1 New Biologics and Targeted Therapies In 2024, Bimekizumab-bkzx was approved for treating adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA)
- Breakthrough Treatment for Rheumatoid Arthritis: Latest Updates
The latest breakthrough treatment for rheumatoid arthritis in 2025 include medications like nonsteroidal anti-inflammatory drugs, corticosteroids, disease-modifying antirheumatic drugs, Jak inhibitors, and biologic inhibitors
- Overview of the management of rheumatoid arthritis in adults
(See "Epidemiology of, risk factors for, and possible causes of rheumatoid arthritis" and "Pathogenesis of rheumatoid arthritis" ) An overview of the management of RA is reviewed here The initial therapy of RA, the treatment of patients resistant to initial and subsequent DMARDs, and nonpharmacologic treatment strategies are discussed in
- New RA Drugs: What’s the Latest? - HealthCentral
The Most Promising New Rheumatoid Arthritis Treatments JAF inhibitors, TNF blockers, and even neurostimulation are bringing relief and renewed hope to people with RA
- Rheumatoid Arthritis: Treatment Advances Reduce Pain, Slow Progression
While joint pain and swelling are common symptoms of more than 100 different forms of arthritis, rheumatoid arthritis (RA) can damage more than a person’s joints Rheumatoid arthritis, an autoimmune disease that is second only to the degenerative “wear-and-tear” disease of osteoarthritis, affects about 1 5 million people in the United States When left untreated, rheumatoid arthritis
- EULAR Updates Recommendations for Managing RA - Medscape
BARCELONA, Spain — Patients with rheumatoid arthritis (RA) who have not responded to first-line methotrexate therapy should be started on a biologic or targeted synthetic disease-modifying
- Current Science Events - Arthritis Foundation
2025 Rheumatoid Arthritis Research Request for Proposals (RFP) Letters of Intent Due: Monday, June 2, 2025, at 2 PM ET This Request for Proposals invites applications that seek to better understand and predict the development, progression, and treatment response of RA
- 5 Research Studies to Watch in 2025 - Arthritis Research Canada
Treatment results for inflammatory arthritis with new medications, known as biologics and targeted synthetic medications, have been impressive They are effective at reducing inflammation, relieving symptoms, and preventing joint damage and long-term complications
|
|